LIMK2 and colorectal cancer: Previous studies have demonstrated that low expression of LIMK2 in colorectal cancer enhanced the accumulation of β-catenin in the nucleus to activate Wnt signaling pathway and promote tumor progression, while high expression of LIMK2 inhibited the proliferation and migration of tumor cells [22].